Steven Perrin

CIK: 0001824545

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ELDN

Eledon Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ELDN
Eledon Pharmaceuticals, Inc.
Jul 31, 2026
Award(A)
Direct
152.4K shares-
ELDN
Eledon Pharmaceuticals, Inc.
Jul 31, 2026
Tax Payment(F)
Direct
72.1K shares at avg. $3.38$244K
ELDN
Eledon Pharmaceuticals, Inc.
Jan 10, 2025
Award(A)
Stock Option (right to buy)
Direct
243K shares-
ELDN
Eledon Pharmaceuticals, Inc.
Jan 10, 2025
Award(A)
Restricted Stock Units
Direct
27K shares-
ELDN
Eledon Pharmaceuticals, Inc.
Nov 21, 2024
Award(A)
Stock Option (right to buy)
Direct
840.4K shares-

		Type	Shares	Price		Ownership
Jul 31, 2026	ELDN Eledon Pharmaceuticals, Inc.	Award(A)	152,353	-	$0	Direct
Jul 31, 2026	ELDN Eledon Pharmaceuticals, Inc.	Tax Payment(F)	72,138	$3.38	$243,826	Direct
Jan 10, 2025	ELDN Eledon Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	243,000	-	-	Direct
Jan 10, 2025	ELDN Eledon Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	27,000	-	-	Direct
Nov 21, 2024	ELDN Eledon Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	840,438	-	-	Direct

1-5 of 5 transactions

About Perrin Steven

Perrin Steven (SEC CIK 0001824545) files insider reports with the SEC as President of Eledon Pharmaceuticals, Inc. (ELDN).

Signal8 holds 3 ownership filings by Perrin Steven, all Form 4s, filed between Nov 22, 2024 and Aug 4, 2026. Those filings report 5 transactions, from Nov 21, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Perrin Steven's filings is in IRVINE, CA.

Recent filings by Perrin Steven

Jul 31, 2026: Grant or award of ELDN shares (Form 4, code A).
Jul 31, 2026: Tax withholding of ELDN shares (Form 4, code F).
Jan 10, 2025: Grants or awards of ELDN derivative securities (2 lines, Form 4, code A).
Nov 21, 2024: Grant or award of ELDN derivative securities (Form 4, code A).

Other insiders filing for Eledon Pharmaceuticals, Inc. (ELDN)

Gros David-Alexandre C, Chief Executive Officer
McBride John S., Director
Hillson Jan, Director
Kirk Allan, Director
Katkin Keith, Director
Lee June, Director

How to read Form 4 transaction codes